Pharyngitis: Difference between revisions
(Move calculators to own section with header (visible in TOC), expanded, before External Links) |
(Strip excess bold) |
||
| Line 92: | Line 92: | ||
===Key Evaluation Principles=== | ===Key Evaluation Principles=== | ||
*Do | *Do not test patients with clear viral features ([[cough]], [[rhinorrhea]], hoarseness, oral ulcers, [[conjunctivitis]]) — treat supportively<ref name="idsa2012"/><ref name="idsa2025"/> | ||
*Do | *Do not routinely test children <3 years of age (both GAS and [[acute rheumatic fever]] are rare), unless risk factors (e.g., sibling with GAS)<ref name="idsa2012"/> | ||
*The 2025 IDSA guideline update recommends using a standardized clinical scoring system (e.g., Modified Centor/McIsaac) to identify low-risk patients who do not need testing<ref name="idsa2025"/> | *The 2025 IDSA guideline update recommends using a standardized clinical scoring system (e.g., Modified Centor/McIsaac) to identify low-risk patients who do not need testing<ref name="idsa2025"/> | ||
*For those meeting testing criteria: use Rapid Antigen Detection Test (RADT) | *For those meeting testing criteria: use Rapid Antigen Detection Test (RADT) | ||
| Line 101: | Line 101: | ||
*Centor/McIsaac score of 0-1: do not test, treat symptomatically | *Centor/McIsaac score of 0-1: do not test, treat symptomatically | ||
*Centor/McIsaac score of ≥2: test with RADT (± backup culture in children) | *Centor/McIsaac score of ≥2: test with RADT (± backup culture in children) | ||
*Do | *Do not test asymptomatic contacts routinely<ref name="idsa2012"/> | ||
*Do | *Do not perform test of cure after treatment unless history of [[acute rheumatic fever]] or recurrent GAS complications<ref name="idsa2012"/> | ||
===Additional Testing to Consider (When Clinically Indicated)=== | ===Additional Testing to Consider (When Clinically Indicated)=== | ||
| Line 112: | Line 112: | ||
==Management== | ==Management== | ||
===Symptomatic Treatment=== | ===Symptomatic Treatment=== | ||
* | *Analgesics/antipyretics are the foundation of treatment for ALL pharyngitis (viral and bacterial) | ||
**[[Ibuprofen]] 400-600mg PO q6h PRN (adults); 10 mg/kg PO q6h PRN (pediatric) | **[[Ibuprofen]] 400-600mg PO q6h PRN (adults); 10 mg/kg PO q6h PRN (pediatric) | ||
**[[Acetaminophen]] 1000mg PO q6h PRN (adults); 15 mg/kg PO q4-6h PRN (pediatric) | **[[Acetaminophen]] 1000mg PO q6h PRN (adults); 15 mg/kg PO q4-6h PRN (pediatric) | ||
**Ibuprofen may be slightly more effective for throat pain than acetaminophen<ref name="mahp"/> | **Ibuprofen may be slightly more effective for throat pain than acetaminophen<ref name="mahp"/> | ||
**Avoid [[aspirin]] in children ([[Reye syndrome]]) | **Avoid [[aspirin]] in children ([[Reye syndrome]]) | ||
* | *Topical therapies: | ||
**Salt water gargle | **Salt water gargle | ||
**Viscous [[lidocaine]] (adults) — use with caution due to aspiration risk | **Viscous [[lidocaine]] (adults) — use with caution due to aspiration risk | ||
**Consider "magic mouthwash" ([[diphenhydramine]]/[[lidocaine]]/antacid mixture) | **Consider "magic mouthwash" ([[diphenhydramine]]/[[lidocaine]]/antacid mixture) | ||
* | *Hydration: encourage oral fluids, soft diet; assess ability to tolerate PO before discharge | ||
===[[Antibiotics]]=== | ===[[Antibiotics]]=== | ||
| Line 128: | Line 128: | ||
*Treatment is indicated for laboratory-confirmed GAS pharyngitis (RADT or culture positive)<ref name="idsa2012"/> | *Treatment is indicated for laboratory-confirmed GAS pharyngitis (RADT or culture positive)<ref name="idsa2012"/> | ||
*'''Do not''' treat empirically based on clinical features alone in most cases<ref name="idsa2025"/> | *'''Do not''' treat empirically based on clinical features alone in most cases<ref name="idsa2025"/> | ||
* | *Goal: prevent [[acute rheumatic fever]], reduce suppurative complications, improve symptoms, decrease transmission | ||
* | *Key point: antibiotics shorten symptom duration by approximately 1-2 days when started early<ref name="spinks">Spinks A, Glasziou PP, Del Mar CB. Antibiotics for treatment of sore throat in children and adults. Cochrane Database Syst Rev. 2021;12:CD000023.</ref> | ||
===[[Steroids]]=== | ===[[Steroids]]=== | ||
| Line 141: | Line 141: | ||
*Discharge home with symptomatic treatment ± antibiotics | *Discharge home with symptomatic treatment ± antibiotics | ||
*Patient can return to work/school after ≥24 hours of antibiotic therapy and clinical improvement (for confirmed GAS)<ref name="cdc">CDC. Clinical Guidance for Group A Streptococcal Pharyngitis. Centers for Disease Control and Prevention. Updated November 2025. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/strep-throat.html</ref> | *Patient can return to work/school after ≥24 hours of antibiotic therapy and clinical improvement (for confirmed GAS)<ref name="cdc">CDC. Clinical Guidance for Group A Streptococcal Pharyngitis. Centers for Disease Control and Prevention. Updated November 2025. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/strep-throat.html</ref> | ||
* | *Return precautions: | ||
**Unable to tolerate oral fluids | **Unable to tolerate oral fluids | ||
**Worsening sore throat or new difficulty swallowing despite treatment | **Worsening sore throat or new difficulty swallowing despite treatment | ||
Latest revision as of 09:32, 22 March 2026
Background
- 1-2% of all ED visits[1]
- Viral is most common cause (~70% in children, ~90% in adults)[2]
- Exudates do not mean bacterial — most common cause of exudative pharyngitis is still viral
- Common viral etiologies: Rhinovirus, Coronavirus, Adenovirus, Influenza, Coxsackievirus, EBV
- Bacterial causes:
- Group A Streptococcus (GAS): most important bacterial cause
- Group C and G Streptococcus: can cause pharyngitis but do not cause acute rheumatic fever
- Fusobacterium necrophorum: increasingly recognized cause in adolescents/young adults (may cause up to 10-20% of pharyngitis in this age group); can lead to Lemierre's syndrome[3]
- Neisseria gonorrhoeae: consider in sexually active patients with pharyngitis and relevant exposure history
- Corynebacterium diphtheriae: rare in developed countries; consider in unvaccinated or recent travelers
Streptococcal pharyngitis
- Accounts for 5-15% of pharyngitis in adults and 15-30% in children[4]
- Peak incidence in ages 5-15 years
- Rare in children <3 years of age (typically presents as "streptococcosis" with rhinitis/low-grade fever rather than classic pharyngitis)
- Seasonal: winter and early spring
- Treatment can be delayed for up to 9 days from symptom onset and still prevent acute rheumatic fever[5]
Clinical Features
General
- Sore throat
- Painful swallowing (odynophagia)
- Fever
- Nausea and vomiting
- Tonsillar exudate
- Anterior cervical lymphadenopathy
- Palatal petechiae
Features Favoring Bacterial (GAS) Etiology
- Sudden onset sore throat
- Fever ≥38.3°C (101°F)
- Tonsillar exudate
- Tender anterior cervical lymphadenopathy
- Absence of cough, rhinorrhea, conjunctivitis, hoarseness, or oral ulcers[5]
Features Favoring Viral Etiology
- Cough
- Rhinorrhea
- hoarseness
- Oral ulcers
- Conjunctivitis
- Diarrhea
- Characteristic viral exanthems (e.g., hand-foot-and-mouth disease)
- Viral symptoms reduce likelihood but do not exclude GAS (test positivity still ~23-28% with viral symptoms present)[6]
Classic Clues for Specific Diagnoses
- Post-treatment with amoxicillin/ampicillin → diffuse pruritic maculopapular rash = classic for EBV pharyngitis (infectious mononucleosis)
- Unilateral sore throat, "hot potato" voice, trismus, uvular deviation = peritonsillar abscess
- Sore throat with high fever progressing to unilateral neck swelling/pain and sepsis in a young adult = consider Lemierre's syndrome[7]
- Gray pharyngeal membrane in unvaccinated patient = Diphtheria
- Vesicular/ulcerative lesions on posterior pharynx = Herpangina or HSV
- Pharyngitis with splenomegaly, posterior cervical lymphadenopathy, fatigue = infectious mononucleosis
- Pharyngitis with diffuse lymphadenopathy, rash, oral ulcers = consider acute HIV
Modified Centor Criteria[8]
One point is given for each of the criteria:[8]
- Absence of a cough
- Swollen and tender cervical lymph nodes
- Temperature >38.0 °C (100.4 °F)
- Tonsillar exudate or swelling
- Age less than 15^
- Subtract a point if age >44
| Points | Probability of Streptococcal pharyngitis |
|---|---|
| 1 or fewer | <10% |
| 2 | 11–17% |
| 3 | 28–35% |
| 4 or 5 | 52% |
ED Red Flags
- Stridor, drooling, tripoding → evaluate for epiglottitis, retropharyngeal abscess, or other airway emergency
- Inability to tolerate secretions or worsening dysphagia
- Toxic appearance / signs of sepsis
- Unilateral neck swelling with persistent high fevers → consider Lemierre's syndrome or deep neck space infection
- Floor of mouth swelling → Ludwig's angina
- Trismus → peritonsillar abscess, deep neck space infection
Complications
Suppurative
- Peritonsillar abscess
- Retropharyngeal abscess
- Cervical lymphadenitis
- Mastoiditis
- Lemierre's syndrome (septic thrombophlebitis of the internal jugular vein)[7]
Nonsuppurative
- Acute rheumatic fever (prevented by antibiotics if started within 9 days)
- Post-streptococcal glomerulonephritis (NOT prevented by antibiotics)
- Scarlet fever
- Toxic shock syndrome
- Pediatric autoimmune neuropsychiatric disorder associated with group A streptococci (PANDAS)
Differential Diagnosis
Acute Sore Throat
Bacterial infections
- Streptococcal pharyngitis (Strep Throat)
- Neisseria gonorrhoeae
- Diphtheria (C. diptheriae)
- Bacterial Tracheitis
Viral infections
- Infectious mononucleosis (EBV)
- Patients with peritonsillar abscess have a 20% incidence of mononucleosis [9]
- Laryngitis
- Acute Bronchitis
- Rhinovirus
- Coronavirus
- Adenovirus
- Herpesvirus
- Influenza virus
- Coxsackie virus
- HIV (Acute Retroviral Syndrome)
Noninfectious
Other
- Deep neck space infection
- Peritonsillar Abscess (PTA)
- Epiglottitis
- Kawasaki disease
- Penetrating injury
- Caustic ingestion
- Lemierre's syndrome
- Peritonsillar cellulitis
- Lymphoma
- Internal carotid artery aneurysm
- Oral Thrush
- Parotitis
- Post-tonsillectomy hemorrhage
- Vincent's angina
- Acute necrotizing ulcerative gingivitis
Oral rashes and lesions
- Angioedema
- Aphthous stomatitis
- Herpes gingivostomatitis
- Herpes labialis
- Measles (Koplik's spots)
- Perioral dermatitis
- Oral thrush
- Steven Johnson syndrome
- Streptococcal pharyngitis
- Tongue diagnoses
- Vincent's angina
Evaluation
Rapid Antigen Detection Test Algorithm for Acute Pharyngitis[10]
| Category | Testing and Treatment |
| Clinical features strongly suggesting viral etiology (eg. cough, rhinorrhea, hoarseness, oral ulcers) |
|
| <3 years old |
|
| CENTOR = 1 |
|
| None of the above with CENTOR ≥2 |
|
Diagnostic testing or empiric treatment of asymptomatic household contacts of patients with acute streptococcal pharyngitis is not routinely recommended
Key Evaluation Principles
- Do not test patients with clear viral features (cough, rhinorrhea, hoarseness, oral ulcers, conjunctivitis) — treat supportively[5][4]
- Do not routinely test children <3 years of age (both GAS and acute rheumatic fever are rare), unless risk factors (e.g., sibling with GAS)[5]
- The 2025 IDSA guideline update recommends using a standardized clinical scoring system (e.g., Modified Centor/McIsaac) to identify low-risk patients who do not need testing[4]
- For those meeting testing criteria: use Rapid Antigen Detection Test (RADT)
- RADT sensitivity 70-90%, specificity >95%
- In children/adolescents: a negative RADT should be backed up with a throat culture (higher false-negative rate)[5]
- In adults: backup throat culture generally not required (lower incidence and lower risk of acute rheumatic fever)[5]
- Centor/McIsaac score of 0-1: do not test, treat symptomatically
- Centor/McIsaac score of ≥2: test with RADT (± backup culture in children)
- Do not test asymptomatic contacts routinely[5]
- Do not perform test of cure after treatment unless history of acute rheumatic fever or recurrent GAS complications[5]
Additional Testing to Consider (When Clinically Indicated)
- Monospot / heterophile antibody for suspected infectious mononucleosis (note: 25% false-negative in first 10 days of illness)[12]
- Gonorrhea NAAT for suspected gonococcal pharyngitis
- CT neck with contrast if concern for deep neck space infection, peritonsillar abscess, or Lemierre's syndrome
- HIV testing if risk factors and clinical features suggest acute retroviral syndrome
Management
Symptomatic Treatment
- Analgesics/antipyretics are the foundation of treatment for ALL pharyngitis (viral and bacterial)
- Ibuprofen 400-600mg PO q6h PRN (adults); 10 mg/kg PO q6h PRN (pediatric)
- Acetaminophen 1000mg PO q6h PRN (adults); 15 mg/kg PO q4-6h PRN (pediatric)
- Ibuprofen may be slightly more effective for throat pain than acetaminophen[2]
- Avoid aspirin in children (Reye syndrome)
- Topical therapies:
- Salt water gargle
- Viscous lidocaine (adults) — use with caution due to aspiration risk
- Consider "magic mouthwash" (diphenhydramine/lidocaine/antacid mixture)
- Hydration: encourage oral fluids, soft diet; assess ability to tolerate PO before discharge
Antibiotics
Treatment can be delayed for up to 9 days and still prevent major sequelae
Penicillin Options:
- Penicillin V 250mg PO BID x 10d (child) or 500mg BID x 10d (adolescent or adult)[13][14]
- Bicillin L-A <27 kg: 0.6 million units; ≥27 kg: 1.2 million units IM x 1[13][15]
- Amoxicillin 50 mg/kg once daily (maximum = 1000 mg) for 10 days[16]
Penicillin allergic (mild):
- Cephalexin 20 mg per kg PO BID (maximum 500 mg per dose) x 10 days[17]
- Cefadroxil 30 mg per kg PO QD (maximum 1 g daily) x 10 days[18]
Penicillin allergic (anaphylaxis):[13]
- Clindamycin 7 mg/kg/dose TID (maximum = 300 mg/dose) x 10 days[19]
- Azithromycin 12 mg/kg PO once (maximum = 500 mg), then 6 mg/kg (max=250 mg) once daily for the next 4 days[20]
- Clarithromycin 7.5 mg/kg/dose PO BID (maximum = 250 mg/dose) x 10 days[21]
Pediatric Dosing:
- Amoxicillin 50mg/kg PO once daily x 10 days (max 1000mg)
- Penicillin V <27kg: 250mg PO BID-TID x 10 days; >27kg: 500mg PO BID-TID x 10 days
- Penicillin G Benzathine <27kg: 600,000 units IM x 1; >27kg: 1.2 million units IM x 1
- PCN allergy (mild): Cephalexin 20mg/kg PO BID x 10 days (max 500mg/dose)
- PCN allergy (mild): Cefadroxil 30mg/kg PO daily x 10 days (max 1g)
- PCN allergy (severe): Azithromycin 12mg/kg PO day 1 (max 500mg), then 6mg/kg daily x 4 days (max 250mg)
- PCN allergy (severe): Clindamycin 7mg/kg/dose PO TID x 10 days (max 300mg/dose)
- PCN allergy (severe): Clarithromycin 7.5mg/kg PO BID x 10 days (max 250mg/dose)
- Clindamycin 7mg/kg/dose PO q8h x 10 days[22]; Max: 300mg/dose
- Azithromycin Children ≥2 years and Adolescents: Oral: 12mg/kg/dose once daily for 5 days (maximum: 500mg daily)
- Amoxicillin 50mg/kg PO q24h x 10 days[23]; Max: 1000mg/day
- Clarithromycin >6mo: 15mg/kg/day PO divided q12h x 7-10d
- Cephalexin 40mg/kg/day PO divided q12h x 10 days; Max: 500mg/dose
- Cefpodoxime 100mg q 12 h for 5-10 days
- Cefuroxime 250mg PO bid x10 days
- Cefuroxime 250mg PO bid x10 days
- Treatment is indicated for laboratory-confirmed GAS pharyngitis (RADT or culture positive)[5]
- Do not treat empirically based on clinical features alone in most cases[4]
- Goal: prevent acute rheumatic fever, reduce suppurative complications, improve symptoms, decrease transmission
- Key point: antibiotics shorten symptom duration by approximately 1-2 days when started early[24]
Steroids
- In adults consider single dose of dexamethasone 0.6mg/kg PO (Max = 10mg)[25]
- Reduces pain severity and time to onset of pain relief (~4-12 hours faster resolution)
- In children consider single dose of dexamethasone 0.6mg/kg PO (Max = 10mg)[26]
- Note: The 2012 IDSA guideline did not recommend routine adjunctive corticosteroids; however, emergency medicine literature supports their use for pain relief[5]
Disposition
Discharge (Majority of Patients)
- Discharge home with symptomatic treatment ± antibiotics
- Patient can return to work/school after ≥24 hours of antibiotic therapy and clinical improvement (for confirmed GAS)[27]
- Return precautions:
- Unable to tolerate oral fluids
- Worsening sore throat or new difficulty swallowing despite treatment
- Difficulty breathing or changes in voice
- Persistent or worsening fever after 48 hours of antibiotics
- New unilateral neck swelling or stiffness
Consider Admission
- Inability to tolerate oral fluids (especially in children) → IV hydration
- Concern for airway compromise
- Sepsis or toxic appearance
- Suspected deep neck space infection, Lemierre's syndrome, or other suppurative complication requiring IV antibiotics and imaging
ED Pearls
- Most sore throats are viral — focus on symptom management and avoid unnecessary antibiotics
- Centor Criteria help identify who does NOT need testing (score 0-1), not who has strep
- Exudate ≠ bacterial; viral pharyngitis frequently causes exudates
- Treatment for GAS can be safely delayed up to 9 days and still prevent acute rheumatic fever — you do not need to prescribe empiric antibiotics from the ED without testing
- Think about Fusobacterium necrophorum and Lemierre's syndrome in any adolescent or young adult with a prolonged, severe, or worsening sore throat, especially with lateral neck pain/swelling or signs of sepsis[3]
- Post-streptococcal glomerulonephritis is NOT prevented by antibiotic treatment (unlike acute rheumatic fever)
- Infectious mononucleosis + amoxicillin/ampicillin = maculopapular rash (present in up to 70-100% of cases)
- Consider acute HIV in any patient with a mononucleosis-like illness and negative Monospot
- Always assess for ability to tolerate PO fluids before discharging pharyngitis patients, particularly young children
Calculators
Centor/McIsaac Score
| Criteria | No (0) | Yes (+1) |
|---|---|---|
| Tonsillar exudates or swelling | 0 | 1 |
| Tender/swollen anterior cervical lymph nodes | 0 | 1 |
| Temperature >38°C (100.4°F) | 0 | 1 |
| Absence of cough | 0 | 1 |
| Age modifier (McIsaac modification) | ||
| Age 3–14 years | 0 | 1 (+1) |
| Age 15–44 years | (0 points — default) | |
| Age ≥45 years | 0 | -1 (−1) |
| Modified Centor Score | 0 / 5 | |
| Interpretation & Management | |
|---|---|
| ≤0 | ~1–2.5% strep probability — No testing or antibiotics needed. |
| 1 | ~5–10% strep probability — No testing or antibiotics needed (optional rapid strep if high clinical suspicion). |
| 2–3 | ~11–35% strep probability — Rapid strep testing recommended; treat if positive. |
| 4–5 | ~51–53% strep probability — Consider empiric antibiotics or rapid strep test. |
| References |
|---|
|
See Also
- Sore Throat
- Streptococcal pharyngitis
- Peritonsillar abscess
- Lemierre's syndrome
- Infectious mononucleosis
- Retropharyngeal abscess
- Epiglottitis
- EBQ:TOAST Trial
References
- ↑ Hildreth AF, Takhar S, Clark MA, Hatten B. Evidence-Based Evaluation And Management Of Patients With Pharyngitis In The Emergency Department. Emerg Med Pract. 2015;17(9):1-16.
- ↑ 2.0 2.1 Michigan Quality Improvement Consortium. Acute Pharyngitis in Children (3 years and older), Adolescents and Adults Guideline. 2025.
- ↑ 3.0 3.1 Centor RM. Expand the pharyngitis paradigm for adolescents and young adults. Ann Intern Med. 2009;151(11):812-815.
- ↑ 4.0 4.1 4.2 4.3 Barshak MB, Dien Bard J, Linder J, et al. 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America: Diagnosis of Group A Streptococcal Pharyngitis. Clin Infect Dis. 2025.
- ↑ 5.0 5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 5.9 Shulman ST, Bisno AL, Clegg HW, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):e86-102.
- ↑ Fine AM, Nizet V, Mandl KD. Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis. Arch Intern Med. 2012;172(11):847-852.
- ↑ 7.0 7.1 Kuppalli K, Livorsi D, Talati NJ, Osborn M. Lemierre's syndrome due to Fusobacterium necrophorum. Lancet Infect Dis. 2012;12(10):808-815.
- ↑ 8.0 8.1 Choby BA (March 2009). "Diagnosis and treatment of streptococcal pharyngitis". Am Fam Physician 79 (5): 383–90. PMID 19275067.
- ↑ Melio, Frantz, and Laurel Berge. “Upper Respiratory Tract Infection.” In Rosen’s Emergency Medicine., 8th ed. Vol. 1, n.d.
- ↑ Shulman, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2012;55(10):1279–82
- ↑ David Cisewski An Understated Myth? Strep Throat & Rheumatic Fever
- ↑ Beyea JA, et al. Pharyngitis: Approach to diagnosis and treatment. Can Fam Physician. 2020;66(4):251-257.
- ↑ 13.0 13.1 13.2 Shulman, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2012;55(10):1279–82
- ↑ CDC Website, accessed 2026-28-01. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/strep-throat.html
- ↑ CDC Website, accessed 2026-28-01. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/strep-throat.html
- ↑ CDC Website, accessed 2026-28-01. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/strep-throat.html
- ↑ CDC Website, accessed 2026-28-01. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/strep-throat.html
- ↑ CDC Website, accessed 2026-28-01. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/strep-throat.html
- ↑ CDC Website, accessed 2026-28-01. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/strep-throat.html
- ↑ CDC Website, accessed 2026-28-01. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/strep-throat.html
- ↑ CDC Website, accessed 2026-28-01. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/strep-throat.html
- ↑ CDC Website, accessed 2026-28-01. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/strep-throat.html
- ↑ CDC Website, accessed 2026-28-01. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/strep-throat.html
- ↑ Spinks A, Glasziou PP, Del Mar CB. Antibiotics for treatment of sore throat in children and adults. Cochrane Database Syst Rev. 2021;12:CD000023.
- ↑ EBQ:TOAST Trial
- ↑ Olympia RP. The Effectiveness of Oral Dexamethasone in the Treatment of Moderate to Severe Pharyngitis in Children and Young Adults. Acad Emerg Med. 2003;10(5). doi:10.1197/aemj.10.5.434-a
- ↑ CDC. Clinical Guidance for Group A Streptococcal Pharyngitis. Centers for Disease Control and Prevention. Updated November 2025. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/strep-throat.html
